Find out how immunotherapy can improve cancer treatment outcomes and the systemic barriers limiting its widespread use.
Xsensio announced that it closed a $7 million oversubscribed Series A financing round to support its patient monitoring ...
Smart biomedical devices are transforming modern health care, using skin-mounted sensors to capture in-depth health ...
The BPM Vision doesn't actually work with Withings' Cardio Check-Up—you need an ECG-enabled Withings tracker, like the ...
Cybersecurity is more important than ever, as cybercrime losses reached $16.6 billion in 2024, according to the FBI, a staggering 33% uptick from 2023. Credit monitoring services protect your personal ...
In the AMPLIFY study, fixed-duration venetoclax-acalabrutinib reduced the risk of disease progression or death by 35% compared with chemoimmuntherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results